Skip over main navigation
  • Log in
  • Basket: (0 items)
myaware
  • Search
  • Twitter
  • Facebook
  • Instagram
  • Youtube
Shop Become a member Donate
Menu
  • About us
    • About myaware
    • Medical Resource Centre
    • Work For Us
    • Accessibility
  • About Myasthenia
    • Myasthenia
    • Different Types of Myasthenia
  • Living with Myasthenia
    • Newly diagnosed
    • Life with myasthenia
    • Drugs to Avoid
    • Treatments
  • How we help
    • Support
    • Awareness
    • Research
    • Online events
  • Support myaware
    • Our Appeals
    • Fundraise for myaware
    • Volunteer
  • Admin
    • Log in
  • Basket: (0 items)
  • coronavirus-information
  1. Coronavirus Information

Coronavirus information

This page has all of the current information myaware has relating to Coronavirus, vaccines and links to government information.

What is Coronavirus?

Expand

COVID-19 is a disease caused by a new coronavirus that affects the lungs and airways. It is related to viruses that cause the common cold. Unlike the common cold, this virus is new, so nobody has immunity to it.

The entire population is therefore at risk of catching it. It is estimated that as many as 80% of people who catch the virus may experience relatively mild or no symptoms but are able to pass on the infection to others. People who do develop symptoms are at risk of passing it on to others for up around 7 days before symptoms emerge. The commonest symptoms are high fever, cough, or shortness of breath.

People aged over 70, with long-term conditions or a weakened immune system are at risk of developing complications of the infection, including secondary lung infections or damaging excess activity of the immune system.

Some patients with particular neurological conditions, who receive certain treatments for neurological conditions, or who also have other non- neurological conditions are at increased risk of complications of COVID-19.

Published: 21st July, 2021

Updated: 10th February, 2022

Author:

Share this page
  • Email
  • Facebook
  • Twitter

Treatment Information

Expand

High Risk Individuals

The NHS is offering new antibody and antiviral treatments to people with coronavirus (COVID-19) who are at highest risk of becoming seriously ill.

Sotrovimab is an antibody treatment.

Molnupiravir is an antiviral medicine.

Immunodeficiency UK Update RE Treatments 10th Feb 2022

NHS Treatments for coronavirus (COVID-19) 

England Treatments for coronavirus (COVID-19)

Wales (COVID-19)

Scotland Coronavirus Treatments (COVID-19)

Northern Ireland Treatments for coronavirus (COVID-19) 

PANORAMIC Trial

COVID-19 oral antivirals will be evaluated through a new national study called PANORAMIC, run by the University of Oxford. The national study is open to individuals living anywhere in the UK who meet the following criteria:

  • have tested positive for COVID-19 using a PCR test
  • have COVID-19 symptoms that started within the last five days
  • are aged 50 and over, or are aged 18 and over with a health condition that puts them at higher risk of getting seriously ill from Covid 19.

The study will test whether these new oral antiviral treatments can help higher-risk people in the early stages of the coronavirus illness recover faster and therefore reduce the number of people admitted to hospital. 50% of patients will be randomised to receive an antiviral and 50% will receive the current standard of care so the study team can see any difference in the health of those who received the antiviral treatment compared to those who did not. All participants take part from their own homes, without needing to visit a clinic or hospital. The oral treatment will be delivered directly to their home by the trial team. All participants will still be able to access any health care that they would normally expect to receive.

Those eligible can sign up for the trial at the study website.

PANORAMIC Homepage — PANORAMIC (panoramictrial.org)

Published: 6th January, 2022

Updated: 10th February, 2022

Author:

Share this page
  • Email
  • Facebook
  • Twitter

General Guidance, Information and Support

Expand

COVID 19 - Nation specific guidance

England Coronavirus (COVID-19): guidance and support 

Wales Coronavirus (COVID-19) 

Scotland Coronavirus in Scotland 

NI Coronavirus (COVID-19) 

COVID 19 - Guidance for those at higher risk

England COVID-19: guidance for people whose immune system means they are at higher risk - GOV.UK (www.gov.uk)

Scotland 

Wales

Northern Ireland 

Association of British Neurologists

COVID-19 Guidance and Advice - Association of British Neurologists (theabn.org)

Myaware Medical Committee guidance

  • All patients with myasthenia are advised to keep up to date with all Covid vaccinations as offered.
  • Patients and close relatives should continue to utilise precautions such as wearing masks, social distancing and hand washing, particularly when in close proximity to people with an unknown vaccination status.
  • Patients should promote open discussions about prevention of COVID-19 infection, including vaccination, among those with whom they live with, or people they socialise with, and encourage them to get vaccinated to keep everyone safe.
  • If specific questions remain, patients should seek medical advice from their GP or treating neurologist to discuss in more detail their individual clinical situation and estimated risks.

Support from Myaware

If you have questions, contact our support team directly.
Tel:01332 949161 or email [email protected]

For specialist guidance on Benefits, Welfare, Education, Employment, Motoring and much more see our Benefits and Welfare advice page or contact Steve Bradshaw, myaware’s Benefits and Welfare Officer at [email protected] or on 01332 290219.

Published: 6th January, 2022

Updated: 10th February, 2022

Author:

Share this page
  • Email
  • Facebook
  • Twitter

Advocacy

Expand

Myaware has taken the following steps to ensure that the needs and voices of our members are heard with regard to Coronavirus vaccinations:

  • Myaware has written to the Ministers for Health in England, Wales, Scotland and Northern Ireland as well as numerous local MPS to request a statement of intent with regard to plans to protect those who are immunocompromised against the effects of Coronavirus. Here you will find a template letter if you wish to write to your local MP regarding this subject.

Please see attached reply from Maggie Throup MP in response to a letter sent to Caroline Ansell MP by a myaware trustee.

  • Myaware has joined www.nationalvoices.org.uk the leading coalition of health and social care charities in England so that members needs are represented.

  • Myaware is a long term member of the Neurological Alliance www.neural.org.uk The Neurological Alliance is a coalition of more than 80 organisations working together to transform outcomes for the millions of people in England with a neurological condition. They campaign for high quality care and support to meet the individual needs of every person with a neurological condition, at every stage of their life. Myaware recently received the following information from Neurological Alliance regarding their advocacy work on behalf of those who are immunosuppressed or compromised.

Published: 21st July, 2021

Updated: 10th February, 2022

Author:

Share this page
  • Email
  • Facebook
  • Twitter

Q&A RE Coronavirus Vaccines 19th October 2021

Expand

Please read our Q & A on Coronavirus Vaccines in full via the PDF

Updated Covid Q&A October 2021

Published: 21st July, 2021

Updated: 10th February, 2022

Author:

Share this page
  • Email
  • Facebook
  • Twitter

Vaccine Booster information

Expand

On 5 and 19 August 2021 the Joint Committee on Vaccination and Immunisation (JCVI) considered whether some individuals may benefit from a third vaccine dose as part of their primary schedule of COVID-19 vaccination (described henceforth in this document as ‘third primary dose’), you can read more on the Gov.uk website.

Published: 29th September, 2021

Updated: 10th February, 2022

Author:

Share this page
  • Email
  • Facebook
  • Twitter

4th Booster Dose

Expand

Click on the link to find out more information from the NHS about the 4th booster dose

4th Booster Dose

Published: 7th February, 2022

Updated: 10th February, 2022

Author:

Share this page
  • Email
  • Facebook
  • Twitter

Coronavirus Q&A April 2021

Expand

The myaware medical committee have recently put together an interview with Bethan Peach (chair of the myaware medical committee) covering all the frequently asked questions regarding Coronavirus and the vaccines. There is also a transcript of the interview to read. This links to Bethan’s Zoom interview

Watch the interview

You can read a full transcript of the interview here.

Published: 21st July, 2021

Updated: 10th February, 2022

Author:

Share this page
  • Email
  • Facebook
  • Twitter

Working Safely During the Pandemic

Expand

Current government advice on staying COVID safe in the workplace

Published: 21st July, 2021

Updated: 10th February, 2022

Author:

Share this page
  • Email
  • Facebook
  • Twitter

Impact of Pandemic on Neurological Services

Expand

National neurology and neuroscience leaders warn of a perfect storm for services for people with neurological conditions resulting from the pandemic.

The National Neuroscience Advisory Group (NNAG), a group of healthcare professionals, and national and local policy and commissioning leads patient groups working together to improve the quality of care for people living with neurological conditions, has today launched a report which shows the far-reaching impacts of the COVID-19 pandemic on people with neurological conditions and key services on which they rely.

NNAG Press Release

Published: 21st July, 2021

Updated: 10th February, 2022

Author:

Share this page
  • Email
  • Facebook
  • Twitter
Back to top

Showing 10 of 10

Latest

  • Supporting Myaware with Scentsy

    Supporting Myaware with Scentsy

    Any donations made from sale of Scentsy products will be donated through Work for Good (https://workforgood.co.uk ). However, if you’d like to make a general donation to the work of myaware, you can do so on this page. Thanks everyone for your support!

  • Wales Drop-In Zoom

    Wales Drop-In Zoom

    It has become evident that getting together regionally is very important! We'd therefore like to invite you to join us and other members in your area to our drop-in zoom to catch up and connect with each other again.

  • Northern Ireland Drop-In Zoom

    Northern Ireland Drop-In Zoom

    It has become evident that getting together regionally is very important! We'd therefore like to invite you to join us and other members in your area to our drop-in zoom to catch up and connect with each other again.

  • North England Drop-In Zoom

    North England Drop-In Zoom

    It has become evident that getting together regionally is very important! We'd therefore like to invite you to join us and other members in your area to our drop-in zoom to catch up and connect with each other again.

Most read

  • Drugs to Avoid

    Drugs to Avoid

    Reactions to drugs are specific to the individual. Nature has made the ignition system very secure.

  • The Extraocular Muscles

    The Extraocular Muscles

    The extraocular muscles are the six muscles that control the movements of the eyes.

  • Ocular Myasthenia

    Ocular Myasthenia

    Ocular myasthenia is a form of myasthenia in which the extraocular muscles, the muscles that control the eyes and eyelids, are easily fatigued and weakened.

  • Pyridostigmine Information

    Pyridostigmine Information

    common questions patients ask about pyridostigmine.

  • Myasthenia Gravis

    Myasthenia Gravis

    Myasthenia gravis (MG) is an autoimmune condition. Your own antibodies will attack communications between your brain and muscle movements.

  • Steroid Information Sheet

    Steroid Information Sheet

    Steroids are a type of medication called an immunosuppressant.

  • LEMS

    LEMS

    Lambert-Eaton myasthenic syndrome (LEMS) is an autoimmune condition. Your antibodies attack the nerve endings and stop muscles contracting causing muscle fatigue.

  • Driving

    Driving

    People with myasthenia MUST inform the DVLA that they have the condition.

  • Intravenous Immunoglobulin

    Intravenous Immunoglobulin

    IVIg is given intravenously into a vein via an infusion pump.

  • Living with Myasthenia

    Living with Myasthenia

    Read our top tips on how to live with myasthenia including information you may find useful.

Contact us

  • Find us
  • 01332 290 219
  • [email protected]

Useful links

  • Sitemap
  • Terms & Conditions
  • Privacy Policy
  • Contact
  • Complaints
  • Shop
  • Accessibility
  • Browsealoud
  • Medical Professionals

Myaware is a Registered Charity No. England & Wales 1046443. Scotland SC044744. Company Limited by Guarantee No. 3038358 (England)

  • Twitter
  • Facebook
  • Instagram
  • Youtube